These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37499961)
1. Overexpressed CD44 is associated with B-cell activation via the HA-CD44-AIM2 pathway in lupus B cells. Yi P; Cao P; Yang M; Xiong F; Jiang J; Mei Y; Xin Y; Zhao M; Wu H; Lu Q Clin Immunol; 2023 Oct; 255():109710. PubMed ID: 37499961 [TBL] [Abstract][Full Text] [Related]
2. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Yang M; Long D; Hu L; Zhao Z; Li Q; Guo Y; He Z; Zhao M; Lu L; Li F; Long H; Wu H; Lu Q Signal Transduct Target Ther; 2021 Sep; 6(1):341. PubMed ID: 34521812 [TBL] [Abstract][Full Text] [Related]
3. AIM2 facilitates the apoptotic DNA-induced systemic lupus erythematosus via arbitrating macrophage functional maturation. Zhang W; Cai Y; Xu W; Yin Z; Gao X; Xiong S J Clin Immunol; 2013 Jul; 33(5):925-37. PubMed ID: 23479181 [TBL] [Abstract][Full Text] [Related]
4. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development. Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226 [TBL] [Abstract][Full Text] [Related]
5. The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps. Antiochos B; Trejo-Zambrano D; Fenaroli P; Rosenberg A; Baer A; Garg A; Sohn J; Li J; Petri M; Goldman DW; Mecoli C; Casciola-Rosen L; Rosen A Elife; 2022 May; 11():. PubMed ID: 35608258 [TBL] [Abstract][Full Text] [Related]
6. Absent in Melanoma 2 proteins in SLE. Choubey D; Panchanathan R Clin Immunol; 2017 Mar; 176():42-48. PubMed ID: 28062222 [TBL] [Abstract][Full Text] [Related]
7. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice. Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702 [TBL] [Abstract][Full Text] [Related]
8. The IL-21-TET2-AIM2-c-MAF pathway drives the T follicular helper cell response in lupus-like disease. Wu H; Deng Y; Long D; Yang M; Li Q; Feng Y; Chen Y; Qiu H; Huang X; He Z; Hu L; Yin H; Li G; Guo Y; Du W; Zhao M; Lu L; Lu Q Clin Transl Med; 2022 Mar; 12(3):e781. PubMed ID: 35343082 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway. Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432 [TBL] [Abstract][Full Text] [Related]
10. Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling. Rizzello C; Cancila V; Sangaletti S; Botti L; Ratti C; Milani M; Dugo M; Bertoni F; Tripodo C; Chiodoni C; Colombo MP Mol Cancer; 2022 Dec; 21(1):215. PubMed ID: 36503430 [TBL] [Abstract][Full Text] [Related]
12. Patterns of ANA+ B cells for SLE patient stratification. Suurmond J; Atisha-Fregoso Y; Barlev AN; Calderon SA; Mackay MC; Aranow C; Diamond B JCI Insight; 2019 May; 4(9):. PubMed ID: 31045579 [TBL] [Abstract][Full Text] [Related]
13. Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus. Jin X; Chen J; Wu J; Lu Y; Li B; Fu W; Wang W; Cui D Front Immunol; 2022; 13():928359. PubMed ID: 36119056 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice. Zhang X; Wang G; Bi Y; Jiang Z; Wang X Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317 [TBL] [Abstract][Full Text] [Related]
15. Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation. Du Y; Du L; He Z; Zhou J; Wen C; Zhang Y Int Immunopharmacol; 2019 Sep; 74():105677. PubMed ID: 31177018 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus. Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340 [TBL] [Abstract][Full Text] [Related]
17. CD4 Jiang J; Yang M; Zhu H; Long D; He Z; Liu J; He L; Tan Y; Akbar AN; Reddy V; Zhao M; Long H; Wu H; Lu Q Eur J Immunol; 2024 Jul; 54(7):e2350603. PubMed ID: 38752316 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus. Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus. Luo J; Niu X; Zhang M; Zhang K; Chen M; Deng S Autoimmunity; 2015 Mar; 48(2):80-6. PubMed ID: 25347333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]